|
End-of-day quote
NSE India S.E.
2026-10-28
|
5-day change | 1st Jan Change | ||
| 862.25 INR | +1.33% |
|
-1.26% | +14.74% |
| 09-25 | Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| 08-14 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 |
| Market Cap | 69.4B 729M 654M 603M 547M 1.02B 1.03B 7.22B 2.88B 36.32B 2.73B 2.68B 115B | P/E 2027 * |
29.2x | P/E 2028 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 69.4B 729M 654M 603M 547M 1.02B 1.03B 7.22B 2.88B 36.32B 2.73B 2.68B 115B | EV / Sales 2027 * |
6.99x | EV / Sales 2028 * | 5.59x |
| Free-Float |
28.72% | Yield 2027 * |
-
| Yield 2028 * | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUPRIYA | End-of-day quote | |
Bombay S.E.
| SUPRIYA | Delayed |
Last Transcript: Supriya Lifescience Limited
| 1 day | +1.33% | ||
| 1 week | -1.26% | ||
| Current month | -9.26% | ||
| 1 month | -12.48% | ||
| 3 months | +2.05% | ||
| 6 months | +22.40% | ||
| Current year | +14.74% |
| 1 week | 801 |  | 879.2 |
| 1 month | 801 | | 1,019.8 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 239.8 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 2024-07-31 | |
| Chief Executive Officer | 36 | 2024-07-31 | |
| Director of Finance/CFO | - | 2023-01-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2008-03-25 | |
| Director/Board Member | 41 | 2019-05-31 | |
| Director/Board Member | 36 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | -1.26% | +18.00% | +244.07% | 721M | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.38% | +1.07% | +37.36% | +93.17% | 402.83B | |
| Weighted average by Cap. | +0.44% | +0.71% | +43.68% | +89.04% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 9.94B 104M 93.57M 86.36M 78.35M 146M 148M 1.03B 412M 5.2B 391M 383M 16.48B | 12.42B 130M 117M 108M 97.93M 183M 185M 1.29B 515M 6.5B 489M 479M 20.59B |
| Net income | 2.37B 24.91M 22.34M 20.62M 18.71M 34.87M 35.35M 247M 98.31M 1.24B 93.46M 91.5M 3.93B | 3.12B 32.79M 29.4M 27.14M 24.62M 45.89M 46.53M 325M 129M 1.63B 123M 120M 5.18B |
| Net Debt | - | - |
Employees
607
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | ₹862.25 | +1.33% | 199,541 |
| 26-10-27 | ₹850.90 | +2.14% | 91,955 |
| 26-10-26 | ₹833.05 | +1.77% | 90,442 |
| 26-10-23 | ₹818.55 | -2.12% | 162,923 |
| 26-10-22 | ₹836.25 | -0.75% | 112,881 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
